Abhaykumar Malind Gupta
YOU?
Author Swipe
View article: Delayed adverse reactions in whole blood donors
Delayed adverse reactions in whole blood donors Open
Background & objectives: The information available regarding delayed adverse donor reactions (D-ADRs) is limited. Proactive follow up of donors for delayed reactions is not done routinely. This study was undertaken to analyze frequency and…
View article: Blood donor deferral periods after COVID-19 vaccination
Blood donor deferral periods after COVID-19 vaccination Open
View article: Impact of the novel coronavirus disease and lockdown on the packed red blood cells inventory management: An experience from a tertiary care oncology center in Western India
Impact of the novel coronavirus disease and lockdown on the packed red blood cells inventory management: An experience from a tertiary care oncology center in Western India Open
View article: Daratumumab Interference with Immunohematology Testing in a Nonmultiple Myeloma Neutropenic Patient, in Need of Granulocyte Transfusion
Daratumumab Interference with Immunohematology Testing in a Nonmultiple Myeloma Neutropenic Patient, in Need of Granulocyte Transfusion Open
Daratumumab (DARA) may interfere with immunohematology tests by binding to endogenous CD38 present on the surface of the red blood cells. DARA was Food and Drug Administration approved for refractory multiple myeloma patients, but now its …
View article: A Case Report of Apheresis Granulocyte Concentrates and the Whole Blood-Derived Pooled Buffy Coat Transfusions in a Neutropenic Hematopoietic Stem Cell Transplant Recipient
A Case Report of Apheresis Granulocyte Concentrates and the Whole Blood-Derived Pooled Buffy Coat Transfusions in a Neutropenic Hematopoietic Stem Cell Transplant Recipient Open
Granulocytes may be procured either as apheresis granulocyte concentrate (AGC) or as a pooled buffy coat granulocytes (PBCG) derived from whole blood donations. The chronic myelomonocytic leukemia patient with active pneumocystis pneumonia…
View article: Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India
Organization of the outdoor blood donation drives amid novel coronavirus pandemic and national lockdown: An experience from a tertiary care oncology institution in India Open
View article: Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India
Challenges in platelet inventory management at a tertiary care oncology center during the novel coronavirus disease (COVID-19) pandemic lockdown in India Open
View article: Challenges and Solutions to Continuing Medical Education amid Novel Coronavirus Disease (COVID-19) Pandemic and National Lockdown in India
Challenges and Solutions to Continuing Medical Education amid Novel Coronavirus Disease (COVID-19) Pandemic and National Lockdown in India Open
View article: First Indian initiative for preparation of low-titer group “O” single-donor platelets with platelet additive solution
First Indian initiative for preparation of low-titer group “O” single-donor platelets with platelet additive solution Open
O group SDPs can be prepared with PAS and the beneficial effects were significant with respect to antibody titers. Quality parameters were well maintained. Availability of PAS units has benefitted patients.
View article: Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India
Therapeutic leukocyte reduction for acute and chronic myeloid leukemias: A 4-year experience from an oncology center in India Open
TLR is a safe and effective therapy for leukoreduction in hematological malignancies in our experience.